Pfizer's Prevenar 13® receives approval for use in infants and children in China
|
02 November 2016 |
Pfizer awarded grant to evaluate vaccine to protect newborns against group B Streptococcus infection
|
19 October 2016 |
Pfizer decides remaining one company best positions company to maximize future value creation
|
26 September 2016 |
Pfizer launches new "Moodivator" app to help support, encourage and motivate people with depression
|
14 September 2016 |
Pfizer appoints chief scientific officer for neuroscience research
|
08 September 2016 |
Pfizer to acquire small molecule anti-infective business from AstraZeneca
|
24 August 2016 |
Pfizer announces publication of new analysis showing long-term therapy with VYNDAQEL (tafamidis) slowed progression of rare neurodegenerative disease
|
12 August 2016 |
Pfizer aims to become industry leader in gene therapy with acquisition of Bamboo Therapeutics, Inc.
|
02 August 2016 |
Pfizer receives World Health Organization prequalification for multi-dose vial presentation of Prevenar 13®
|
19 July 2016 |
Merck and Pfizer initiate Phase III trial to evaluate Avelumab as first-line treatment for ovarian cancer
|
07 July 2016 |
Pfizer completes acquisition of Anacor
|
24 June 2016 |
Help Pfizer change the future of healthy aging
|
21 June 2016 |
Pfizer presents promising data from next generation ALK/ROS1 inhibitor in advanced non-small cell lung cancer
|
06 June 2016 |
Merck and Pfizer to present Avelumab data in seven different cancers at ASCO annual meeting
|
19 May 2016 |
Pfizer awards more than $1 million in metastatic breast cancer research funding
|
13 May 2016 |
Pfizer reports first-quarter 2016 results
|
03 May 2016 |
Pfizer announces termination of proposed combination with Allergan
|
07 April 2016 |
Bristol-Myers Squibb and Pfizer announce global real-world data program and present new analyses of Eliquis (apixaban)
|
30 March 2016 |
Pfizer celebrates a year of achievements in 2015 annual review
|
16 March 2016 |
Pfizer commences $5 billion accelerated share repurchase
|
11 March 2016 |